Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02938377 · ClinicalTrials.gov registry record · Phase 4
Alcohol Research Consortium in HIV-Intervention Research Arm
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 4,985
- Enrollment target
NCT02938377: Completed Phase 4 study, sponsored by University of Alabama at Birmingham.
NCT02938377 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 4,985 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (862% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02938377, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 4,985 participants
- Enrollment target
Study Summary
Aim 1: Examine effects of algorithm-guided alcohol treatment on alcohol consumption and alcohol use Disorders (AUD) symptoms. Aim 2: Examine effects of algorithm-guided alcohol treatment on retention in HIV care and HIV-related outcomes. Aim 3: Examine effects of algorithm-guided alcohol treatment on comorbid conditions
Primary Outcome
Difference in Audit-C score, pre and post intervention. The AUDIT-C is scored on a scale of 0-12 (scores of 0 reflect no alcohol use). In men, a score of 4 or more is considered positive; in women, a score of 3 or more is considered positive. Generally, the higher the AUDIT-C score, the more likely it is that the patient's drinking is affecting his/her health and safety.
Interventions
- BEHAVIORAL CBT4CBT
- BEHAVIORAL Computerized Brief Intervention (CBI)
- DRUG Recommendation and Counseling for Alcohol Pharmacotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,985 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2023-11-01 |
| Phase | Phase 4 |
What the finished NCT02938377 record still lists
NCT02938377 is an interventional study that assigns participants to a tested intervention. Its 4,985 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (862% higher).
The record links to 0 conditions, and to 3 interventions - of which CBT4CBT is the first listed.
NCT02938377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02938377 about?
NCT02938377 is a clinical study titled "Alcohol Research Consortium in HIV-Intervention Research Arm". Aim 1: Examine effects of algorithm-guided alcohol treatment on alcohol consumption and alcohol use Disorders (AUD) symptoms. Aim 2: Examine effects of algorithm-guided alcohol treatment on retention in HIV care and HIV-related outcomes. Aim 3: Examine effects of algorithm-guided alcohol treatment...
What is the current status of trial NCT02938377?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 4,985 participants. The study started on 2017-11-06. Estimated completion is 2023-11-01.
What interventions are being tested in trial NCT02938377?
The interventions under investigation include: CBT4CBT (BEHAVIORAL), Computerized Brief Intervention (CBI) (BEHAVIORAL), Recommendation and Counseling for Alcohol Pharmacotherapy (DRUG).
Who is sponsoring clinical trial NCT02938377?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02938377's enrollment target sits among peer trials
4,985 16th of 2000 higher than 1,985 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI